Medtronic Bolsters Sinus Portfolio With $1.1Bn Intersect ENT Buyout

Medtronic announced plans to acquire Intersect ENT, adding its sinus implants to Medtronic's portfolio of devices used by surgeons in treating chronic rhinosinusitis.

Acquisition

More from Deals

More from Business